Propofol attenuates sepsis-induced acute kidney injury by regulating miR-290-5p/CCL-2 signaling pathway by Guodong Zheng (714597)

“…We found that miR-290-5p was a direct regulator of CCL-2 in MPC5. …”

Data Sheet 1_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.pdf by Evan Fuini (21224939)

Table 4_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

Data Sheet 2_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.docx by Evan Fuini (21224939)

Table 1_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.docx by Evan Fuini (21224939)

Table 5_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

Table 2_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

Table 3_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

A model with two target-cell populations and viral competition in one of these populations matches <i>in vivo</i> data and predicts that R5 inhibitors accelerate AIDS onset. by Ariel D. Weinberger (169848)

“…For the “non-competitive regime,” parameter values are: <i>λ</i> = 33 cells/(µl•day), <i>c</i> = 23/day, <i>p</i> = 2100/day, <i>f</i> = 0.8, <i>δ</i> = 0.5/day, <i>k_N4</i> = 0.00108 µl/(virions•day), <i>k_M4</i> = 4•10⁻⁵ µl/(virions•day), and <i>k_M5</i> = 0.0068 µl/(virions•day), while in the “competitive regime” we change <i>k_M4</i> to 5•10⁻⁴ µl/(virions•day) and <i>k_N4</i> to 0.001 µl/(virions•day) (decreased in order to keep X4 in check). …”

Figure 5 Rectal epithelial EGL-10 acts downstream of serotonin to modify the immune response and affect pathogen clearance by Rachel Mcmullan (506214)

“…<p>Treatment of wild type animals with 3.8mg/ml 5-HT caused a decrease in the number of Dar animals following infection with M. nematophilum (A) and decreased the clearance of SYTO13 labeled pathogen from the rectal opening (B). …”

RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

The relative expression of abscisic acid-related genes, including <i>GmABI5</i>, <i>GmABI4</i>, and <i>GmDREB1</i> in soybean seeds dip-treated with control, H30-3 extract (H30-3E)... by Sang Tae Kim (6017996)

Stability study results of a) & b) are ACE and CAP at 40°C±2°C/75%RH±5%RH, c) & d) are ACE and CAP at 25°C±2°C/60%RH±5%RH, e) & f) are ACE and CAP at 2–8°C. by Jaganmohan Somagoni (532859)

Kinetics of alpaca innate immune responses in the lungs following MERS-CoV Qatar15/2015 infection. by Nigeer Te (7849808)

The capacity to neutralize free viruses prior to completion of CD4 attachment varies across bnAb classes. by Lucia Reh (546554)

“…<p><b>A:</b> Schematic of free virus infection of A3.01-CCR5 target cells to measure total and pre-attachment activity of bnAbs. …”

S2 Table - by Penny A. Rudd (10298691)

Kinetics of alpaca innate immune responses at the nasal submucosa in response to MERS-CoV Qatar15/2015. by Nigeer Te (7849808)

“…TFs, transcription factors; CKs, chemokines; ADs, adaptors; RT, receptor. MERS-CoV+ and MERS-CoV-, MERS-CoV positive and negative epithelium areas as assessed by IHC, respectively. …”

Kinetics of alpaca innate immune responses at the tracheal level in response to MERS-CoV Qatar15/2015. by Nigeer Te (7849808)

M2b group mean (and standard error) lines of best fit for the normalized integrated wrist flexor EMG values as a function of trial-by-trial foreperiod length. by Christopher J. Forgaard (3210876)

Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension by Akira Naito (663843)

“…Initial screening was performed in 5 CTEPH patients and 5 healthy donors (HDs) using a ProtoArray Human Protein Microarray v5.1 containing 9,375 human proteins, and we selected 34 antigens recognized by IgG antibodies more strongly in the sera of CTEPH patients than in the sera of HDs. …”